CYP2C9 Promoter Variable Number Tandem Repeat Polymorphism Regulates mRNA Expression in Human Livers

CYP2C9 is involved in metabolism of nearly 25% of clinically used drugs. Coding region polymorphisms CYP2C9*2 and *3 contribute to interperson variability in drug dosage and clinical outcomes, whereas the role of a regulatory polymorphism remains uncertain. Measuring allelic RNA expression in 87 hum...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wang, Danxin, Sun, Xiaochun, Gong, Yan, Gawronski, Brian E., Langaee, Taimour Y., Shahin, Mohamed Hossam A., Khalifa, Sherief I., Johnson, Julie A.
Formato: Artigo
Lenguaje:Inglês
Publicado: The American Society for Pharmacology and Experimental Therapeutics 2012
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3336799/
https://ncbi.nlm.nih.gov/pubmed/22289258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.111.044255
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares